Neuroscience
| Name | Price | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | Login | Bimekizumab Biosimilar - Anti-IL17A, IL17F mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Abituzumab Biosimilar - Anti-ITGAV , CD51 mAb - Research Grade | Login | Abituzumab Biosimilar - Anti-ITGAV , CD51 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Abituzumab Biosimilar - Anti-ITGAV , CD51 mAb - Research Grade | Login | Abituzumab Biosimilar - Anti-ITGAV , CD51 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Emibetuzumab Biosimilar - Anti-MET, RCCP2 mAb - Research Grade | Login | Emibetuzumab Biosimilar - Anti-MET, RCCP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Emibetuzumab Biosimilar - Anti-MET, RCCP2 mAb - Research Grade | Login | Emibetuzumab Biosimilar - Anti-MET, RCCP2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Necitumumab Biosimilar - Anti-EGFR, ERBB1 mAb - Research Grade | Login | Necitumumab Biosimilar - Anti-EGFR, ERBB1 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Necitumumab Biosimilar - Anti-EGFR, ERBB1 mAb - Research Grade | Login | Necitumumab Biosimilar - Anti-EGFR, ERBB1 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | Login | Secukinumab Biosimilar - Anti-IL17A mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Carlumab Biosimilar - Anti-CCL2, MCP-1, MCAF, SCYA2 mAb - Research Grade | Login | Carlumab Biosimilar - Anti-CCL2, MCP-1, MCAF, SCYA2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Carlumab Biosimilar - Anti-CCL2, MCP-1, MCAF, SCYA2 mAb - Research Grade | Login | Carlumab Biosimilar - Anti-CCL2, MCP-1, MCAF, SCYA2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fulranumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | Login | Fulranumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fulranumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | Login | Fulranumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | Login | Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | Login | Ponezumab Biosimilar - Anti-APP Abeta40 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | Login | Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | Login | Brodalumab Biosimilar - Anti-IL17RA, CD217 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade | Login | Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade | Login | Vatelizumab Biosimilar - Anti-ITGA2 mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fasinumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | Login | Fasinumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| Fasinumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | Login | Fasinumab Biosimilar - Anti-NGF, NGFB mAb - Research Grade | ||||||||||||||||
|
||||||||||||||||||
| BCR-ABL Protein / BCR/ABL p210 fusion protein (BCR/ABL fusion) | Login | BCR-ABL Protein / BCR/ABL p210 fusion protein (BCR/ABL fusion) | ||||||||||||||||
|
||||||||||||||||||
| BCR/ABL p210 fusion protein (BCR/ABL fusion) | Login | BCR/ABL p210 fusion protein (BCR/ABL fusion) | ||||||||||||||||
|
||||||||||||||||||
| Glutamine synthetase(GLUL) | Login | Glutamine synthetase(GLUL) | ||||||||||||||||
|
||||||||||||||||||
| EGFR protein / Epidermal growth factor receptor(EGFR) | Login | EGFR protein / Epidermal growth factor receptor(EGFR) | ||||||||||||||||
|
||||||||||||||||||


